EFALIZUMAB
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Integrin alpha-L/beta-2 (LFA-1) inhibitor | no | 4 | 0 |
| Drug Type | Action Type | Mechanism of Action | Approved | Max Trial Phase | Max GBM Phase |
|---|---|---|---|---|---|
| Antibody | INHIBITOR | Integrin alpha-L/beta-2 (LFA-1) inhibitor | no | 4 | 0 |